Schonfeld Strategic Advisors’s Rapid Micro Biosystems RPID Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-352,433	Closed	-$1.02M	–	2605
2025 Q4	$1.02M	Sell	352,433 -294,146	-45%	-$1.02M	﹤0.01%	1120
2025 Q3	$2.16M	Sell	646,579 -391,089	-38%	-$1.24M	0.01%	995
2025 Q2	$3.58M	Buy	1,037,668 +8,863	+0.9%	+$25.7K	0.02%	699
2025 Q1	$2.72M	Buy	+1,028,805	New	+$2.35M	0.02%	808
2023 Q4	–	Sell	-15,000	Closed	-$16.2K	–	2167
2023 Q3	$16.2K	Hold	15,000	–	–	﹤0.01%	1568
2023 Q2	$15K	Hold	15,000	–	–	﹤0.01%	1906
2023 Q1	$19.6K	Hold	15,000	–	–	﹤0.01%	1833
2022 Q4	$16.9K	Buy	15,000 +2,500	+20%	+$6.05K	﹤0.01%	2334
2022 Q3	$40K	Buy	12,500 +2,500	+25%	+$9.7K	﹤0.01%	2663
2022 Q2	$43K	Buy	+10,000	New	+$46.5K	﹤0.01%	2242

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

EFA

Evernest Financial Advisors Carmel, Indiana $481M AUM 19.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's RPID Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Rapid Micro Biosystems (RPID) in Q1 2026, closing a stake of 352,433 shares — an estimated $1.02M sold.

Schonfeld Strategic Advisors first reported a position in RPID in Q2 2022 and held it in 10 quarters. The position peaked at $3.58M in Q2 2025. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

Schonfeld Strategic Advisors reported no remaining Rapid Micro Biosystems position as of Q1 2026 after selling out during the quarter.
Schonfeld Strategic Advisors sold 352,433 Rapid Micro Biosystems shares in Q1 2026, an estimated $1.02M.
Schonfeld Strategic Advisors first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 10 quarters.
Schonfeld Strategic Advisors's Rapid Micro Biosystems position peaked at $3.58M in Q2 2025.
46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.